Despite recent advancements in diabetes technology and therapeutics, many patients with type 2 diabetes (T2D) continue to experience suboptimal glycemic management, placing them at an increased risk of diabetes-related complications and ultimately leading to higher health care costs. Previously, the use of diabetes-focused mobile health (mHealth) applications has been associated with improved glycemic management. This poster reports the impact of the mySugr mHealth app on the change in blood glucose tests above range, within range, and below range in patients with T2D and hyperglycemia prior to use of the app using a retrospective analysis of 930 mySugr app users with self-reported T2D in the United States who enrolled between January 1, 2018, and November 30, 2022.
